Nielsen, Rune
Xue, Yaxin
Jonassen, Inge
Haaland, Ingvild
Kommedal, Øyvind
Wiker, Harald G.
Drengenes, Christine
Bakke, Per S.
Eagan, Tomas M. L.
Funding for this research was provided by:
Helse Vest
The Endowment of Timber Merchant A. Delphin and Wife through the Norwegian Medical Association
GlaxoSmithKline through the Norwegian Respiratory Society
Bergen Medical Research Foundation
Article History
Received: 1 June 2021
Accepted: 29 September 2021
First Online: 2 November 2021
Declarations
:
: All participants provided written, informed consent. The study was conducted in accordance with the Helsinki declaration, and was approved by the Regional Ethics Committee of Western Norway (Project Number 2011/1307).
: All authors participated in the revision of the manuscript and approved the final version for submission and publication.
: Dr. Nielsen reports grants from Helse-Vest RHF (the Western Norway Regional Health Authority), grants from GlaxoSmithKline, grants from Boehringer Ingelheim, grants from The Endowment of Timber Merchant Dolphin, during the conduct of the study; personal fees from Boehringer Ingelheim, grants and personal fees from Astra Zeneca, grants from Novartis, outside the submitted work. Mrs. Drengenes reports grants from Boehringer Ingelheim, outside the submitted work. Dr. Bakke reports personal fees from GlaxoSmithKline, personal fees from Chiesi, personal fees from AstraZeneca, personal fees from Boehringer-Ingehem, outside the submitted work. Dr. Eagan reports grants from Helse-Vest RHF (the Western Norway Regional Health Authority), grants from Bergen Medical Research Foundation, during the conduct of the study; personal fees from Boehringer Ingelheim, outside the submitted work. Authors YX, IJ, IH, ØK and HW have no conflicts of interest to disclose.